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IM model has required the assumption 
that all of the populations were constant 
in size, and therefore it has not been useful 
for assessing how descendant populations 
arose or changed in size.
Hey analyzed DNA sequences from nine 
loci, so that the population genetic history 
could be found despite the variation 
among genes. He also added an additional 
parameter to the standard IM model to 
incorporate changes in the size of the 
ancestral population and of each founder 
population through time. The genetic 
data included DNA sequences from 
Asian and American Indian individuals. 
Hey varied the parameters in his model, 
which included founding population 
size, changes in population size, time of 
population formation (and splitting), and 
gene exchange between the populations, 
to work out the demographic scenario 
that best ﬁ  t the available genetic data.
His analysis suggests that only about 
70 individuals left their ancestral Asian 
population, estimated at about 9,000 
individuals, to reach America 7,000 to 
14,000 years ago. Archeological evidence 
places the earliest American inhabitants in 
the New World at around 14,000 years ago. 
Though Hey’s estimates are more recent, 
they also indicate a high probability at this 
time period. Hey did not include genetic 
data from Eskimo-Aleut and Na Déne 
speakers, so the number of migrations 
was not addressed. But with this new 
approach, researchers will be able to 
explore this and many other questions 
to ﬁ  ll in the details of the ﬁ  rst American 
immigration.
Hey J (2005) On the number of New World 
founders: A population genetic portrait 
of the peopling of the Americas. DOI: 
10.1371/journal.pbio.0030193
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About 14,000 years ago—a few 
hundred thousand years after our putative 
modern forebears spread out from 
Africa—descendants of archaic humans 
crossed the Bering land bridge from 
Siberia to North America. Several lines of 
evidence support this model, but that’s 
where the consensus ends. The details 
remain hotly debated, focusing mostly on 
which Asian population migrated, when 
they did it, and whether they did it more 
than once. 
Part of the challenge in reconstructing 
this history stems from the dynamic 
nature of human populations—which 
experience unpredictable changes in 
size, composition, density, and mating 
patterns—and the difﬁ  culty in interpreting 
genetic history. To get a better picture of 
the range of possible scenarios, scientists 
are using new statistical approaches that 
require computer simulations. Jody Hey 
now extends this approach in a novel 
method for the study of the origins of 
New World populations. Along with 
DNA analysis and computer simulations, 
Hey adds a new twist to an old model 
to reveal how the sizes of the ﬁ  rst New 
World populations have changed since 
they were founded. His results fall in line 
with archeological, genetic, and linguistic 
evidence, pointing to a relatively recent 
colonization of the Americas. But they go 
a step further by showing that the New 
World was colonized by a small population 
with an effective size of only about 70 
individuals. (The effective size refers to the 
number of individuals likely to contribute 
genes to the next generation.)
Hey’s approach addresses shortcomings 
in population genetic studies that rely 
on just one gene and that assume that 
population sizes have been constant over 
time. Studying levels of DNA sequence 
variation at a single genomic region, or 
loci, can offer insight into the history of 
that gene, but the stochastic nature of 
gene evolution means that different genes 
have different histories. And as simpliﬁ  ed 
versions of a very complex reality, 
population genetics models, such as the 
“isolation with migration” (IM) model, that 
aim to capture the population dynamics 
during the early stages of divergence or 
speciation have necessary limitations. 
The widely used IM model, for example, 
assumes that a founding population splits 
into two descendant populations that 
may interbreed, and incorporates a large 
number of parameters. But until now the 
From Few to Many: New World Founded by Surprisingly Small Population
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Data from nine different regions in the human genome chart the journey of the ﬁ  rst 
immigration to the New World
Ever since Robert Hooke startled the 
world with ﬁ  nely rendered illustrations 
of “minute bodies” in his 1665 book, 
Micrographia, our understanding of the 
microscopic world within and around us 
has mushroomed with each technological 
advance. Though imaging capability 
has developed light-years beyond the 
compound microscope that inspired 
Hooke’s cork cell epiphany, biologists have 
only recently been able to observe living 
cells in chunks of tissue extracted from an 
organism—an approach that’s critical for 
studying processes like cell differentiation 
and development. 
Ellen Robey and her group study the 
mechanisms of cell differentiation and 
cell fate by tracking T cell development 
in mouse models. In a new study, Colleen 
Witt, Ellen Robey, and their colleagues take 
advantage of a recent innovation called 
two-photon microscopy to visualize the 
migration of developing 
T cells, or thymocytes, in intact thymuses 
extracted from mice. They ﬁ  nd that after 
cells undergo positive selection—which 
Tracking Migrating T Cells in Real Time
DOI: 10.1371/journal.pbio.0030205PLoS Biology  |  www.plosbiology.org 0930
seals their fate as either helper T or killer T 
cells—they make a beeline for the thymus 
interior (called the medulla). Though 
it’s been known that positively selected 
thymocytes migrate to the medulla, this 
study shows that migration follows a clear 
directional course, possibly guided by 
long-range signaling cues.
Because two-photon microscopy can 
penetrate tissue at high resolution without 
distorting or damaging the specimen, the 
authors could characterize thymocytes 
moving through their native tissue 
environment and interacting with the 
molecules and cells they would normally 
encounter. (For more on two-photon 
microscopy, see the Primer by David Piston 
[10.1371/journal.pbio.0030207] and the 
“Tracking the Details of an Immune Cell 
Rendezvous in 3-D” [DOI: 10.1371/journal.
pbio.0030206].) 
In the service of optimum immune 
defense, the mammalian adaptive 
immune system churns out billions of 
T cells a day. Precursor T cells originate 
in the bone marrow and migrate to the 
thymus, where their immune mettle 
is tested by a selection process that 
only about 1% will survive. Immature 
double-positive thymocytes—so-called 
because they have the protein markers 
associated with both helper (CD4) and 
killer (CD8) T cells—inhabit the outer 
thymic layer, called the cortex, while 
single-positive thymocytes—which 
have lost either the CD4 or CD8 marker 
following positive selection—are found 
in the central medulla. How a thymocyte 
reacts to other lymphocytes as it wends 
its way through the thymus determines 
whether it undergoes positive selection 
and matures into a helper or killer T cell 
or undergoes negative selection and 
programmed cell death. The signaling 
cues that guide this process remain 
obscure. 
Witt et al. engineered mice with 
thymocytes tagged with green ﬂ  uorescent 
protein (GFP), removed their thymic 
lobes for microscopic analysis when they 
were 4.5 to 5.5 weeks old, then observed 
the behavior of the glowing cells. The 
GFP cells in the cortex showed distinct 
differences in motility, morphology, and 
migratory behavior: low-motility cells had 
a spherical, nonpolar shape, moved with 
a modestly protruding leading edge, and 
sometimes paused; high-motility cells had 
a clear leading edge that moved in ﬁ  ts 
and starts and never paused. Once on the 
move, high-motility cells mostly hewed 
to a single direction while low motility 
cells often retraced their steps. Unlike the 
low-motility cells, the high-motility cells 
traveled in a linear manner through the 
cortex, suggesting directed migration. 
Since there were so few of the fast-
moving, inwardly migrating cells, the 
authors hypothesized that they had 
undergone positive selection—which 
they went on to conﬁ  rm in transgenic 
mouse models. From these results, Witt et 
al. conclude that positive selection triggers 
a “rapid directional migration pattern.” 
And because that migration corresponds 
to an area of the cortex that extends up to 
200 microns below the outer layer of the 
thymus, it appears to be guided by long-
range signaling cues. 
As often happens in biology, close 
observation of a process reveals more 
complexity and raises more questions 
about the mechanics underlying it. 
Homing in on the source of these long-
range signaling cues and characterizing 
the migratory patterns of the large 
number of slow-moving cells will go a 
long way toward understanding how the 
major components of immunity acquire 
their defensive chops.
Witt CM, Raychaudhuri S, Schaefer, 
Chakraborty AK, Robey EA (2005) Directed 
migration of positively selected thymocytes 
visualized in real time. DOI: 10.1371/
journal.pbio.0030160
Since humans and chimpanzees forged separate evolutionary 
paths some 5 million to 6 million years ago, we shed our hirsute 
coat and heavy brow, mastered bipedal locomotion, and 
acquired a knack for abstract thought while our next of kin 
learned to use tools, created a complex communication system, 
and developed the skills to construct tree-bound nests high 
above the forest ﬂ  oor. We differ by just a tad over 1% at the DNA 
sequence level, yet scientists predict that both species should 
harbor genetic footprints of our divergence. 
One way to ﬁ  nd such genetic signatures is to search for 
genes that reveal signs of natural selection. The assumption is 
that genes or genomic elements touched by natural selection 
will show more functionally signiﬁ  cant molecular changes 
than unaffected regions. A 2003 study by Andrew Clarke et 
al. used this approach to identify human genes affected by 
positive selection—that is, selection that preserves new genetic 
variants—by comparing 7,645 genes from humans to their 
chimp and mouse equivalents. Clarke et al. identiﬁ  ed genes in 
several functional categories, including olfaction and hearing, 
and showed that positively selected genes are more likely to 
contain variations (called single nucleotide polymorphisms, or 
SNPs) associated with genetic diseases. 
In a new study, Rasmus Nielsen, Michele Cargill, and their 
colleagues (many of whom participated in the 2003 study) 
Human and Chimp: Can Our Genes Tell the Story of Our Divergence?
DOI: 10.1371/journal.pbio.0030202
DOI: 10.1371/journal.pbio.0030205.g001
Real-time visualization of thymocytes within intact thymic lobes using two-photon 
microscopy
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Animals with adaptive immunity have 
a secret for dealing with foreign invaders 
like viruses and bacteria—variety. Their 
immune systems generate a diverse array 
of receptors to detect the enormous 
number of components (antigens) that 
make up an invader. But with so many 
potential antigens, it would be difﬁ  cult 
for the immune system to anticipate 
every one and thereby encode a receptor 
gene for each of them. Instead, the 
immune system employs a strategy of 
combinatorial diversity, recombining a 
few genes to give an unlimited supply of 
different receptors. 
The portions of immune receptor 
genes that recombine are called V 
(variable), D (diversity), and J (joining) 
segments. The immune system 
randomly recombines these segments 
in a process called V(D)J recombination. 
This extraordinary reorganization is 
undertaken by two enzymes: RAG1 
and RAG2. How this process evolved in 
animals is a mystery, although it has been 
theorized that RAG1 and RAG2 might 
have evolved from an ancient enzyme, 
called transposase, that could move or 
transpose gene segments. But proof of 
this theory for the origin of RAG’s activity 
has remained elusive. 
In a new study, Vladimir Kapitonov and 
Jerzy Jurka have found that RAG1 is similar 
to transposases encoded by transposons 
(jumping genes that encode transposases 
necessary for their mobility) found in both 
terrestrial and marine organisms: the fruit 
ﬂ  y and malaria-carrying African mosquito 
and the sea urchin and hydra. These 
potentially ancient relatives of RAG1 are all 
called Transib transposons. The discovery 
of their relation to RAG1 supports the 
decades-old hypothesis that V(D)J 
recombination sprung from a transposase. 
A number of different types 
(superfamilies) of transposons exist 
in nature, but no one has been able 
to show that RAG1 or RAG2 evolved 
from them. Kapitonov and Jurka took 
advantage of the recently discovered 
Transib superfamily of transposons to 
reexamine this problem. They used seven 
known Transib transposases from the 
fruit ﬂ  y and malaria-carrying African 
Uncovering the Ancient Source of Immune System Variety 
DOI: 10.1371/journal.pbio.0030212
compared 13,731 known genes in humans to their equivalents 
in chimps to ﬁ  nd positively selected genes in both species. 
Nielsen et al. also identiﬁ  ed many genes involved in sensory 
perception, as well as spermatogenesis, but found the 
strongest evidence for positive selection in genes related to 
immune defense. Immunity genes, the authors explain, were 
likely targeted throughout mammalian evolution, while the 
perception and olfactory genes probably reﬂ  ect primate-
speciﬁ  c adaptations. They also found a “surprising number” of 
tumor-suppression and apoptosis genes. 
Mutations in coding DNA can be broadly classiﬁ  ed into 
two groups: a nucleotide change can cause an amino acid 
substitution that either alters the encoded protein (called 
nonsynonymous mutation) or has no effect (synonymous 
mutation). Nielsen et al. used a statistical method that denotes 
positive selection based on the ratio of nonsynonymous 
to synonymous mutations. Thousands of genes failed to 
unambiguously pass this test, leaving 8,079 for further study; 
those that passed were grouped into functional categories, 
revealing the genes related to immunity, sensory perception, 
and spermatogenesis. Of genes associated with speciﬁ  c tissues, 
only testis-speciﬁ  c genes showed evidence of positive selection. 
Genes expressed in the brain appear to be under selective 
constraints, indicating that the genetic roots of our cognitive 
distance from chimps lies elsewhere, perhaps in how genes are 
regulated or organized.  
The authors followed up the chimp–human comparison by 
analyzing the top 50 genes from their list in a group of African- 
and European-Americans. The data provide further support 
for the conclusion that these genes have undergone positive 
selection.
Nielsen et al. were surprised to ﬁ  nd so many genes involved 
in tumor development and control among the top 50 positively 
selected genes (in both primates). The factors behind this 
pattern are unclear, but the authors suggest that studying 
the genes’ other functions, in immunity or spermatogenesis, 
may offer clues to selective pressures—and it also raises 
some intriguing paradoxes. It could be, for example, that the 
overrepresentation of genes involved in tumor suppression, 
spermatogenesis, and apoptosis sets up competing interests on 
two fronts. Apoptosis normally eliminates up to 75% of sperm 
cells during spermatogenesis; mutations that protect sperm 
cells from apoptosis may be selected for, beneﬁ  ting the cell but 
compromising the ﬁ  tness of the organism. Positive selection 
for apoptosis avoidance in the germ line could subsequently 
increase the probability of cancer in body cells—apoptosis 
routinely eliminates unhealthy cells—pitting the “selﬁ  sh interests 
of a germ cell” against the organism’s interest in avoiding cancer. 
Future studies will have to determine whether these 
explanations—of an evolutionary arms race—prove plausible. 
We’re a long way from understanding why we’re so different 
from our closest primate cousins, but this study provides plenty 
of tools, and hypotheses, to mine the tiny differences in our DNA 
for more clues.
Nielsen R, Bustamante C, Clark AG, Glanowski S, Sackton TB, et al. 
(2005) A scan for positively selected genes in the genomes of humans 
and chimpanzees. DOI: 10.1371/journal.pbio.0030170
DOI: 10.1371/journal.pbio.0030202.g001
Young adult male chimpanzee (Photo: Frans de Waal, Emory 
University)
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mosquito to search the protein database 
GenBank, ﬁ  nding that part of one Transib
transposase, Transib2_AG, was 35%–38% 
identical to part of RAG1. 
This initial relationship only suggested 
that RAG1 might be related to Transib2_
AG, since the similarity between the 
two was only “marginally” statistically 
signiﬁ  cant, leaving the possibility that 
it occurred by chance. To ﬁ  nd more 
statistical evidence of a relationship, 
Kapitonov and Jurka searched for more 
Transib proteins. They found a diverse 
family of Transib transposases in various 
animals, including silkworm, red ﬂ  our 
beetle, dog hookworm, soybean rust, and 
hydra. The authors also found that plants 
and vertebrates appear not to contain 
Transib proteins.    
With the new proteins in tow, 
Kapitonov and Jurka found that 
a 600-amino-acid region of RAG1 
was statistically similar to Transib
transposases. This 600-amino-acid 
region of RAG1 forms the core region 
that mediates V(D)J recombination. 
Three important amino acids, which 
underlie RAG1’s ability to recombine 
gene segments, are also conserved in 
Transib transposases. Furthermore, RAG1 
and RAG2 are known to recombine 
V, D, and J segments by binding to 
speciﬁ  c signals in these genes (called 
recombination signal sequences), which 
appear to have been derived from the 
ends of Transib transposons. It was 
previously thought that both RAG1 and 
RAG2 likely evolved from two proteins 
encoded by the same transposon. 
However, Kapitonov and Jurka could not 
ﬁ  nd any RAG2-like proteins encoded 
by Transib transposons. The authors 
therefore suggest that RAG2 appeared 
later in jawed vertebrates as a necessary 
component for the evolution of V(D)J 
recombination.
With the use of similarity searches 
(using computer programs to identify 
comparable parts of proteins and 
transposons), Kapitonov and Jurka have 
provided support for the transposon 
origin of V(D)J recombination. This theory 
was previously up for debate, as it was 
possible that RAG1 and RAG2 could have 
independently evolved to function like 
transposons. But the authors suggest 
that “these arguments can now be put to 
rest,” as it appears RAG1 evolved from a 
transposon currently found in ﬂ  ies and 
other organisms. Future experiments on 
how Transib transposons work may allow 
further understanding into how RAG1 
and RAG2 evolved and how they function 
in vertebrates.
Kapitonov VV, Jurka J (2005) RAG1 Core 
and V(D)J Recombination signal sequences 
were derived from Transib transposons. 
DOI: 10.1371/journal.pbio.0030181
DOI: 10.1371/journal.pbio.0030212 .g001
A gene involved in V(D)J recombination—
which allows immune cells to recognize 
an unlimited number of antigens by 
reshufﬂ  ing immune receptor gene 
segments—evolved from an ancient gene-
transposing enzyme
The path from DNA to RNA to protein sounds straightforward 
enough, but few processes in the life of a cell could be called 
simple. Gene expression is a complex, highly regulated affair that 
involves the activity of discrete teams of molecular manipulators 
at key steps in the protein production pathway. As soon as 
transcription begins, RNA processing machinery sets to work on 
messenger RNA (mRNA) precursors in the nucleus, proofreading 
the RNA copy, stabilizing the elongating transcripts, and making 
sure mRNAs reach the translation machinery in the cytoplasm. 
A key step in RNA processing involves the addition of a string 
of adenine nucleotides to the 3' end of the growing transcript, 
a modiﬁ  cation called polyadenylation. (Each RNA chain has 
what’s called a 5' end and a 3' end, which relates to the chemical 
polarity of the nucleotides.) In eukaryotes like yeast and humans, 
polyadenylation helps to stabilize the mRNA transcript and to 
ensure its export from the nucleus. Once in the cytoplasm, the 
mRNAs’ poly(A) tails interact with components of the translation 
apparatus and facilitate protein synthesis. Polyadenylation is 
mediated by a class of enzymes called poly(A) polymerases 
(PAPs), which typically act in concert with other proteins in the 
cell’s nucleus. 
Just three years ago, a new class of PAPs was discovered that 
belong to the Trf4/5 family of yeast proteins and are found in the 
cytoplasm, rather than the nucleus, of the cell. Unlike the nuclear 
PAPs, in which one protein contains both catalytic activity and an 
RNA-binding domain, the new class relies on two or more protein 
subunits to carry out these tasks. It’s been suggested that these 
enzymes stabilize speciﬁ  c mRNAs in the cytoplasm by extending 
their poly(A) tails. It’s long been known that adding poly(A) tails 
to RNAs in prokaryotic bacteria promotes the degradation of 
defective RNAs, but the existence of a similar mechanism in yeast 
has just recently come to light. Previous genetic experiments on 
live yeast cells by James Anderson and collaborators suggested 
that when the protein Trf4p polyadenylated a particular type 
of abnormal transfer RNA (tRNA)—the intermediary that 
translates the nucleotide code into the amino acid code—the 
tRNA was destroyed. In a new study, Walter Keller and colleagues 
An Enzyme That Oversees RNA Quality Control 
DOI: 10.1371/journal.pbio.0030191
DOI: 10.1371/journal.pbio.0030191.g001
Model of the tRNA surveillance mechanism via polyadenylation 
of misfolded RNA by Trf4 complex leading to degradation by the 
exosome
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investigate the biochemistry, composition, and function of Trf4p 
in the brewer’s yeast Saccharomyces cerevisiae, and ﬁ  nd evidence 
that Trf4p-mediated polyadenylation plays a role in RNA quality 
control in eukaryotes. 
After showing that mutating two amino acid residues in 
the predicted catalytic center of Trf4p eliminates its activity, 
Keller and coworkers determined that the enzyme forms a PAP 
complex with three other proteins (including two putative RNA-
binding proteins, Air1p and Air2p, and a putative RNA-unwinding 
enzyme called Mtr4p that most likely functions to unwind 
structured regions in the RNAs). They also showed that the Trf4p 
complex selectively targets and successfully polyadenylated 
only tRNA molecules that were either lacking the chemical 
modiﬁ  cations required for normal folding or that were misfolded 
by mutation. Polyadenylation appears to tag the aberrant 
RNA as damaged goods, signaling the cell’s nuclear molecule-
degradation complex, the exosome, to initiate destruction.
Keller and colleagues propose that the Trf4p complex 
recognizes structural defects in RNA, prompting the Trf4p 
subunit to add poly(A) tails to the RNA, which initiates RNA 
degradation. In this model, Trf4p, along with either Air1p or Air2p, 
interacts with the RNA enzyme Mtr4p, which physically connects 
the tRNA-Trf4-PAP complex to the exosome. These results 
suggest that Trf4-PAP monitors the quality of tRNAs by detecting 
misfolded RNAs and engineering their destruction before they 
can gum up the works of protein assembly.
That the polyadenylation pathway for discarding defective 
tRNA appears in both bacteria and yeast suggests that this 
quality-control mechanism represents the ancient role for 
polyadenylation, the authors propose; the stabilization function 
of adding poly(A) tails may have arisen as eukaryotes evolved 
a nucleus and other organelles. Whether this notion or the 
model described here proves correct remains to be seen, and 
the authors outline a number of avenues for further study. 
Determining the structure of RNA–protein complexes, for 
example, and their binding properties and interactions, the 
authors argue, should elucidate the mechanism by which this 
RNA surveillance complex operates and what features of its RNA 
substrates it recognizes.
Va á ová S, Wolf J, Martin G, Blank D, Dettwiler S, et al. (2005) 
A new yeast poly(A) polymerase complex involved in RNA quality 
control. DOI: 10.1371/journal.pbio.0030189
Viruses, small organisms that hijack 
our cellular machinery to replicate 
their genomes and make new viruses, 
constantly threaten human health. Not 
only are we unable to control infections 
caused by old enemies such as the 
cold virus, but we are also continually 
challenged by new enemies, like the 
coronavirus that causes severe acute 
respiratory syndrome (SARS-CoV). 
Vaccines provide one way to deal with 
viruses, but subtle differences between 
how host and viral proteins are made 
may also provide targets for new antiviral 
therapeutics. 
SARS, a life-threatening respiratory 
illness, ﬁ  rst appeared in late 2002. By 
February 2003, Guangdong Province, 
China, was in the grip of a SARS 
epidemic, and public-health ofﬁ  cials 
were predicting that millions of people 
might become infected. The rapid 
implementation of effective containment 
efforts averted this new threat to human 
health, and, in the end, only 8,098 people 
became ill. SARS-CoV, a single-stranded 
RNA virus, was isolated in March 2003 
and its genome sequenced by May 
2003. Since then, researchers have 
intensively studied the virus, hoping to 
identify targets for antiviral therapeutics. 
Jonathan Dinman and colleagues now 
describe a new RNA structural motif in 
the SARS-CoV genome that may provide 
such a target.
During protein synthesis, molecular 
machines called ribosomes move along 
mRNA molecules, translating nucleotide 
triplets into amino acids. In human cells, 
the ribosomes usually hook onto the start 
of an mRNA and decode each triplet in 
turn. However, viral mRNAs often contain 
special signals that tell the ribosomes 
to change register or “frameshift.” This 
allows viruses to coordinate gene 
expression from overlapping coding 
sequences, and it ensures that the 
correct ratios of enzymatic and structural 
proteins are made.
ORF1a and ORF1b are overlapping, 
out-of-frame coding sequences within 
the SARS-CoV genome. Each encodes 
a polyprotein—a large protein that is 
cleaved into smaller, functional proteins. 
Polyprotein 1a is translated directly from 
ORF1a; the fused polyprotein 1a/1b is 
produced by programmed −1 ribosomal 
frameshifting in which the ribosome 
slips back one nucleotide at a special 
signal within the mRNA. Like other 
frameshift signals, the SARS-CoV signal 
contains a pseudoknot, a stable mRNA 
structure. Pseudoknots generally contain 
two stems, in which complementary 
nucleotides form double-stranded RNA, 
and two or three loops of unpaired 
nucleotides. Because the mRNA strand 
passes over and behind itself to form the 
stems, the whole structure looks like a 
small knot of the kind that would unravel 
if its two ends were pulled.
Unexpectedly, a computational analysis 
undertaken by Dinman and his colleagues 
reveals that the pseudoknot in the SARS-
CoV frameshift signal contains three stems. 
The researchers provide further evidence 
for this novel structure by ﬁ  nding potential 
three-stemmed pseudoknots in the 
frameshift signals of other coronaviruses 
and by doing biochemical and structural 
NMR studies on the SARS-CoV signal. They 
also show that the SARS-CoV frameshift 
signal behaves like other viral frameshift 
signals in several frameshifting assays, and 
their mutagenesis studies indicate that 
speciﬁ  c sequences and structures within 
New Frameshifting Pseudoknot Found in SARS Virus
DOI: 10.1371/journal.pbio.0030199
DOI: 10.1371/journal.pbio.0030199.g001
A three-stemmed pseudoknot in SARS 
messenger RNAs could provide a target 
for antiviral therapeutics (Image: Jonathan 
Dinman and the National Institute of 
Allergy and Infectious Diseases)
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In a perfect world, anyone frequenting 
the habitat of malaria-carrying 
mosquitoes would sleep beneath a 
mosquito net, take prophylactic drugs, 
and maybe even quaff quinine-laced 
tonic water. But life is rarely perfect and 
even though governments and the World 
Health Organization have combined such 
prevention measures with widespread 
efforts to eradicate malaria-carrying 
mosquitoes, the disease kills more than a 
million people each year.  
The microbes that cause the disease, 
tiny parasites of the genus Plasmodium,
have a complex life cycle that involves 
several distinct phases and habitats. 
When a person is bitten by an infected 
mosquito, highly mobile Plasmodium
cells (called sporozoites) migrate from 
the skin into the bloodstream, which 
carries them to the liver, where they set 
up shop in liver cells (called hepatocytes) 
and multiply asexually as merozoites. 
Eventually the parasites leave the liver 
and reenter the bloodstream, where they 
invade red blood cells, multiply again, 
and differentiate into new merozoites. 
Ultimately, a red blood cell will become 
so chock-full of merozoites it bursts, 
releasing more merozoites to infect other 
red blood cells. Some of these merozoites 
will differentiate into male and female sex 
cells (called gametocytes) that hitchhike 
along with red blood cells when a new 
mosquito takes a blood meal from an 
infected person. The gametocytes then 
breed within the mosquito and produce 
sporozoites, which reside in the insect’s 
gut—and then the cycle begins all over 
again.
Although much is already known 
about the Plasmodium life cycle, many 
details—including the discrete steps 
that facilitate sporozoites’ invasion of the 
liver—have escaped direct observation 
until now. In a new study, Ute Frevert et al. 
literally take a closer look at this process 
with intravital microscopy—which allows 
direct observation of cell movement in a 
living animal—to see how the parasites 
gain entry into the liver.
To visualize this process, the 
authors used genetically engineered 
Plasmodium parasites to express 
ﬂ  uorescent tags. They introduced these 
ﬂ  uorescent parasites to mice and rats 
the natural way—through mosquito 
bites—and then watched for the 
arrival of the parasites in the livers of 
the test animals. They observed that 
parasites were carried into the liver by 
the bloodstream, and then attached to 
the sinusoidal walls (sinusoids take the 
place of capillaries in the liver). They 
watched as the parasites crawled along 
the interior of the sinusoids—sometimes 
against the direction of blood ﬂ  ow—
until they reached a specialized cell 
called a Kupffer cell. These star-shaped 
cells line the liver sinusoids and clean 
the blood of particulate debris and dead 
blood cells. But they also, apparently, 
serve as the parasites’ portal of entry 
into the liver. 
Earlier work had suggested that 
sporozoites might use Kupffer cells to 
access the liver, but Frevert et al. watched 
sporozoites traverse Kupffer cells to reach 
the liver interior. They observed some 
interesting details in this process: as 
sporozoites enter a Kupffer cell, they ﬁ  rst 
pause, then undergo a slow constriction as 
they insinuate their way through the cell 
(rather like a napkin being drawn through 
a napkin ring). Sporozoites traverse the 
Kupffer cell at a speed much slower than 
they could crawl, indicating that this 
traversal involves more than mere parasite 
locomotion. Upon exiting the Kupffer cell 
on the other side, the sporozoites wreaked 
havoc in the liver, leaving a path of 
destruction and dead cells behind them as 
they moved through several consecutive 
hepatocytes before ﬁ  nally settling down in 
one to begin reproducing.  
Frevert et al. had to make multiple 
attempts and track several different 
sporozoites at each stage in order to 
gain a comprehensive picture of this part 
of the parasite’s life cycle. But thanks to 
the visualization advantages provided 
by using the ﬂ  uorescent parasites and 
intravital microscopy, the authors show 
that it is now possible to directly observe 
events in the Plasmodium life cycle that 
had only been inferred before. 
Frevert U, Engelmann S, Zougbédé S, Stange 
J, Ng B, et al. (2005) Intravital observation 
of Plasmodium berghei sporozoite infection 
of the liver. DOI: 10.1371/journal.
pbio.0030192 
Tracking a Killer: In Vivo Microscopy Reveals Details on the Life Cycle of Malarial Parasites
DOI: 10.1371/journal.pbio.0030215
DOI: 10.1371/journal.pbio.0030215.g001
Tagged with red ﬂ  uorescent protein, the 
malarial parasites in the sporozoite stage 
can be seen migrating along the sinusoids 
in a mouse liver
stem 2 of the pseudoknot are needed for 
efﬁ  cient frameshifting. 
The exact role of the extra stem in the 
SARS-CoV frameshifting signal remains 
to be determined, but the researchers 
speculate that it could help to regulate 
the exact ratio of polyprotein 1a to 
1a/1b. The current results also suggest 
that the three stems may fold back on 
one another to from a complex globular 
RNA structure. The elucidation of this 
structure by high-resolution NMR, the 
researchers say, should facilitate the 
rational development of therapeutic 
agents designed to interfere with 
SARS-CoV programmed −1 ribosomal 
frameshifting and should also increase 
our understanding of how pseudoknots 
stimulate frameshifting.
Plant EP, Pérez-Alvarado GC, Jacobs JL, 
Mukhopadhyay B, Hennig M, et al. (2005) 
A three-stemmed mRNA pseudoknot in the 
SARS coronavirus frameshift signal. DOI: 
10.1371/journal.pbio.0030172
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For a cell, suicide is a perfectly acceptable response to 
stress. Programmed cell death, or apoptosis, is a normal part 
of development: it occurs 131 times over the course of worm 
development, for example, and throughout the life of an 
organism to replenish worn out cells in a variety of tissues. 
Disease and infection also trigger apoptosis. The dying cell 
shrinks into a membrane-bound package that attracts the 
attention of phagocytes, which quickly ingest and degrade the 
cell’s contents. Dendritic cells, specialized phagocytes, patrol 
the body, capturing molecules (or antigens) expressed by a 
host of pathogens, parasites, environmental substances, and 
apoptotic cells, and present their ﬁ  ndings to the helper and 
killer T cells that launch an immune response.
Before dendritic cells can sound the immune alarm, they 
must capture antigens, chop them into peptide fragments, 
and bind the antigenic peptides to molecules of the major 
histocompatibility complex (MHC). Though dendritic cells can 
present to helper or killer T cells, it had been thought that the 
MHC I–bound antigens (recognized by killer T cells) must ﬁ  rst 
enter the dendritic cell’s cytosol and undergo proteasome 
degradation. It was also thought that antigenic peptides 
needed the transporter activity of TAP (transporter associated 
with antigen processing) proteins to escort them into the 
cellular compartment where the MHC I molecules reside.
A new study by Nathalie Blachère, Robert Darnell, and 
Matthew Albert lends support to an emerging view that 
antigen processing may be more ﬂ  exible and suggests that 
dendritic cells can generate MHC I peptides that activate killer 
T cells through cross-presentation. (The phenomenon is called 
cross-presentation because the pathway crosses established 
rules of MHC I antigen presentation.) Working with a mouse 
model to study killer T cell activation in response to inﬂ  uenza 
antigens derived from apoptotic cells, the authors show that 
two distinct pathways mediate antigen processing. In the ﬁ  rst 
pathway, antigen processing in dendritic cells depends on TAP, 
following the established model. But in the second pathway, 
antigens processed by a dying, infected cell can bypass 
the dendritic cells’ degradation machinery yet still permit 
generation of MHC I/peptide complexes that can engage killer 
T cells.
T cells can recognize millions of different antigens because 
each T cell is outﬁ  tted with a unique T cell antigen receptor 
that recognizes a unique MHC/peptide complex. In this study, 
the authors used the activation of inﬂ  uenza-reactive T cells 
as evidence of antigen presentation. To test the hypothesis 
that dying cells can process antigen for cross-presentation, 
Blachère et al. limited the dendritic cells’ ability to process 
antigen by using cells extracted from the bone marrow of mice 
lacking functional TAP proteins. If the cells could provoke a T 
cell response, then antigen-speciﬁ  c MHC I/peptide complexes 
would have to arise through an alternate pathway. 
When TAP-deﬁ  cient dendritic cells were directly infected 
with inﬂ  uenza, they could not elicit a T cell response. But when 
infected dying cells were internalized by the TAP-deﬁ  cient 
dendritic cells, the dendritic cells were able to cross-present 
inﬂ  uenza antigen and activate the T cells. To investigate the 
mechanism of cross-presentation, the authors generated 
cells with deﬁ  cient proteasomes that could not degrade 
viral proteins, and also used another cell line inhibited in TAP 
activity. When either of these cell types were infected with 
inﬂ  uenza, caused to undergo apoptosis, and engulfed by 
dendritic cells, it became clear that the dendritic cells needed 
functional TAP to successfully present the inﬂ  uenza antigen to 
T cells. The authors then went on to validate the operation of 
these pathways in vivo.
Altogether, these results point to two MHC I pathways: one 
relies on transporter activity in the dendritic cell; the other 
allows dendritic cells to capture antigens already processed 
in the dying cell. Though the details of the cross-presentation 
pathway remain unclear, the conditions that give rise to it are 
not: when dendritic cells are directly infected, they mediate 
antigen processing. When dendritic cells ingest already 
infected, apoptotic cells, the dying cells deliver processed 
antigen and set the stage for cross-presentation. It’s possible 
that stressful conditions, like an inﬂ  uenza infection, trigger this 
cross-presentation pathway, allowing the dying cell to alert the 
immune system to a pathogenic agent that requires immediate 
action. 
Blachère NE, Darnell RB, Albert ML (2005) Apoptotic cells deliver 
processed antigen to dendritic cells for cross-presentation. DOI: 
10.1371/journal.pbio.0030185
A Dying Cell’s Last Hurrah: Flagging the Remnants of a Fatal Infection
DOI: 10.1371/journal.pbio.0030197
DOI: 10.1371/journal.pbio.0030197.g001
Antigenic proteins in the cytosol are degraded by the proteasome 
and transported by TAP into the MHC1 compartment for MHC1 
loading (Image: Giovanni Maki)
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freed double-strand ends signal that DNA 
damage has occurred and activate the 
cell’s repair pathway.  
According to Ryan Cirz et al., DNA 
damage, induced by antibiotics or 
other stressors, sets off a bacterium’s 
emergency repair mechanism: the SOS 
DNA damage response. Under normal 
conditions, the genes are turned off by 
a special repressor protein called LexA. 
In response to the damaged DNA, the 
LexA repressor is cleaved and no longer 
inhibits transcription of the SOS response 
genes. Cirz et al. propose that antibiotic-
mediated DNA damage generates 
a reduction in the concentration of 
LexA that is sufﬁ  cient to increase the 
expression of three nonessential DNA 
polymerases shown to be required for 
mutation: Pol II (encoded by the gene 
polB), Pol IV (encoded by dinB), and Pol 
V(encoded by umuD and umuC). Together 
these polymerases promote DNA 
repair—and cause mutations in bacterial 
DNA that can lead to antibiotic resistance.
This suggests that quinolone 
antibiotics (and other antibiotics that 
cause similar kinds of DNA damage) 
may increase the likelihood that bacteria 
will evolve resistance and that new 
generations of drugs will have little 
chance of succeeding where today’s 
drugs have failed. But all hope is not 
lost. After showing that the evolution 
of quinolone resistance depends on 
activating the SOS response genes gated 
by LexA, Cirz et al. go on to demonstrate 
that blocking LexA cleavage, in vitro and 
in a mouse model, prevents mutation 
and results in bacteria that are unable 
to evolve antibiotic resistance. Thus, 
developing novel therapeutic agents 
that target LexA or the associated 
SOS pathway may prove a promising 
strategy for controlling the spread of the 
superbugs. 
Cirz RT, Chin JK, Andes DR, de Crécy-
Lagard V, Craig WA, et al. (2005) Inhibition 
of mutation and combating the evolution of 
antibiotic resistance. DOI: 10.1371/journal.
pbio.0030176
The development of antibiotic drugs 
changed the face of clinical medicine 
forever, and, for a short while at least, it 
seemed that a perfect cure for bacterial 
infections had been discovered. But 
widespread overuse and misuse of 
antibiotics over the last several decades 
has proved the Achilles heel of this 
once seemingly invincible class of drugs 
and has fostered bacterial resistance to 
conventional antibiotic therapies. New 
drugs are continually being developed 
to replace those crippled by resistance, 
but despite scientists’ best efforts, new 
“superbugs” are evolving faster than the 
drugs required to control them. 
For some time now, drug resistance 
has been considered a consequence of 
errors (called mutations) that accumulate 
spontaneously during replication of the 
bacterial genome. In many cases those 
mutations are either inconsequential 
or harmful to the bacteria, but on rare 
occasion, they provide an accidental 
beneﬁ  t: resistance to the drugs that 
kill them. Because the mutations were 
assumed to be spontaneous, there was 
no obvious way to prevent them and 
thus antibiotic resistance appeared 
inevitable. But some researchers are 
taking a pro-active approach by testing 
the assumptions about how mutations 
are made. For one group of bacterial 
researchers, this approach may have paid 
off. 
Chemists at the Scripps Research 
Institute and the University of Wisconsin 
have uncovered evidence that 
spontaneous mutations are not the only 
way in which bacteria acquire resistance 
to antibiotics. It appears that the bacteria, 
rather than passively waiting around 
for a lucky break, may play an active 
role in their own evolution. The key is in 
the way antibiotics interact with their 
bacterial targets. Quinolone antibiotics 
are a relatively new class of antibiotics 
that work by interfering with proteins 
called topoisomerases, which assist DNA 
replication by loosening tightly wound 
DNA and making it accessible. In order 
to do this, the topoisomerase must break 
the DNA strands and ﬁ  ll in the gap with a 
temporary protein bridge. Under normal 
circumstances, the bridge is removed 
and the DNA is reconnected after the 
topoisomerase has done its job, but 
quinolones bind to this protein bridge 
and prevent the DNA from resealing. The 
Bacterial SOS May Be the Key to Combating Antibiotic Resistance
DOI: 10.1371/journal.pbio.0030221
DOI: 10.1371/journal.pbio.0030221.g001
Inhibiting a protein involved in DNA repair 
in bacteria might prevent mutations that 
promote antibiotic resistance, prolonging 
the effectiveness of ciproﬂ  oxacin and other 
quinolone antibiotics
If you stopped to consider the 
potentially pathogenic encounters 
waiting outside your door on any given 
day, you might never leave home. Then 
you would just have to contend with 
the billions of microbes reproducing on 
your toothbrush and kitchen sponge. 
Of course, most of us safely navigate 
our microbe-ﬁ  lled world thanks to an 
immune system that manufactures 
billions of lymphocytes a day, in case any 
of those microbes proves malicious. 
Lymphocytes arise in the bone 
marrow, where B lymphocytes mature; 
T lymphocyte precursors migrate to the 
thymus to mature. Both T and B cells then 
travel to distinct regions in the spleen 
and lymph nodes—B cells amassing in 
follicles and T cells in T zones—in search 
of alien antigens. After encounters with 
antigen, B and T lymphocytes migrate to 
the edges of their respective zones and 
compare notes. These B cell–helper T cell 
interactions are essential for an effective 
B cell–mediated antibody response. 
One would not expect such crucial 
interactions to be left to chance alone, 
but evidence of directed migration has 
not been generated—until now. 
In a new study, Takaharu Okada and 
Jason Cyster at the University of California 
at San Francisco together with Mark Miller 
and Mike Cahalan at the University of 
California at Irvine and several colleagues 
used a groundbreaking technology called 
two-photon microscopy to visually inspect 
intact lymph nodes extracted from mice 
to investigate this lymphocyte rendezvous. 
Tracking the Details of an Immune Cell Rendezvous in 3-D
DOI: 10.1371/journal.pbio.0030206
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If a novel oxygen-producing metabolic pathway hadn’t 
evolved in ancient microbes over 3 billion years ago, it’s unclear 
whether humans and other oxygen-dependent species would 
have either. But evolve we did, adapted to having just the 
right level of oxygen coursing through our blood—too little 
oxygen (hypoxia) causes headaches, nausea, and eventually 
death. Patients with acute respiratory distress syndrome (ARDS) 
and other serious lung injuries routinely receive oxygenation 
therapy to facilitate oxygen delivery to deprived tissues. But 
too much oxygen (hyperoxia) kills, too. Hyperoxia produces 
free radicals, causing oxidative damage to cells and tissues by 
disrupting cellular components. And recent evidence suggests 
that oxygenation therapy might produce dangerous side 
effects in patients with ARDS who also have severe pulmonary 
inﬂ  ammation.
In a new study, Manfred Thiel et al., in a team led by Michail 
Sitkovsky, test the hypothesis that oxygenation weakens a 
tissue-protecting mechanism triggered by hypoxia. Working with 
gene-altered mice, the team of immunologists, pathologists, and 
biochemists ﬁ  nds evidence that clinical oxygenation treatments 
Hypoxia to the Rescue: When Oxygen Therapies Backﬁ  re
DOI: 10.1371/journal.pbio.0030211
DOI: 10.1371/journal.pbio.0030211.g001
Lung tissue under ambient oxygen levels (left) and under 100% 
oxygen (right), which exacerbates acute inﬂ  ammatory lung injury
They discovered a combination of 
random and directed behaviors: 
antigen-engaged B cells move 
randomly along the follicle 
outskirts, then undergo directed 
migration near the follicle/T-
zone border as they home in on 
their helper T counterparts. (For 
more on two-photon microscopy, 
see the Primer by David Piston 
[10.1371/journal.pbio.0030207] 
and “Tracking Migrating T Cells in 
Real Time” [DOI: 10.1371/journal.
pbio.0030205].)
Once a B cell recognizes an 
antigen via immunoglobulin 
receptors on its surface, it will 
not proliferate, differentiate into 
a plasma cell, and generate mass 
quantities of antibodies without 
the go-ahead from a helper T cell. 
To investigate the dynamics of 
this process, Okada, Miller, and 
colleagues transferred ﬂ  uorescently 
labeled HEL-speciﬁ  c transgenic B 
cells, or Ig-tg B cells (engineered 
to secrete antibodies against the model 
antigen, hen egg lysozome [HEL]), and 
nonaltered B cells into mice with identical 
genetic backgrounds. An hour after HEL 
injections, lymph nodes were removed 
from the mice for microscopic analysis. 
The Ig-tg B cells were “fully occupied” 
by HEL antigen and—unlike the naïve 
(unengaged) non-Ig-tg cells—had begun 
to aggregate along the edge of the 
follicles.
After antigen binding, the Ig-tg cells 
grew sluggish compared to naïve cells, 
then headed for the B-zone/T-zone (B/T) 
border. Half of the primed cells reached 
the B/T boundary, compared to 20% of 
the naïve cells, and did so by (mostly) 
taking a path that was closer to a straight 
line—a sign of directed migration. 
Ratios of path length plotted against 
displacement from the path show that 
antigen-engaged B cells tacked toward 
the boundary when they got within 
about 140 microns of it. 
The authors go on to show that 
antigen-engaged B cells need the 
chemokine receptor CCR7 to follow 
directions to the T zone—which 
contains an abundant supply of CCR7’s 
signaling protein, or ligand—CCL21. 
Besides concentrating in the T 
zone, CCL21 also showed up in 
follicles, in an increasing gradient 
from the follicle periphery to 
the boundary. Okada, Miller, and 
colleagues studied interactions 
between antigen-engaged B cells 
and activated helper T cells in 
a transgenic mouse model and 
found that only B and T cells with 
cognate antigens formed stable 
pairs, which moved at the B cells’ 
discretion. 
Based on these ﬁ  ndings, the 
authors conclude that once 
antigen-engaged, B cells follow 
the long-range chemokine 
gradient to the B/T boundary. 
After arrival at the boundary the 
B cells can undergo multiple, 
even polygamous, contacts with 
T cells—which might facilitate 
optimal pairings—before B 
cell proliferation and antibody 
production begins. Whether 
promiscuous and monogamous 
liaisons produce different B cell reactions 
is unclear. And though CCR7 helps B 
cells ﬁ  nd the border, it’s not clear what 
keeps them there. But thanks to the T 
lymphocyte–B lymphocyte dynamics 
outlined here, immunologists have plenty 
of avenues for exploring these questions 
to further elucidate the complex 
interactions underlying an effective 
antibody attack.
Okada T, Miller MJ, Parker I, Krummel MF, 
Neighbors M, et al. (2005) Antigen-engaged 
B cells undergo chemotaxis toward the T 
zone and form motile conjugates with helper 
T cells. DOI: 10.1371/journal.pbio.0030150
DOI: 10.1371/journal.pbio.0030206.g001
Two-photon microscopy reveals the three-dimensional 
dynamics of B cell (red) and T cell (green) conjugate within 
lymph tissue in real time
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In 1972, John Kerr, Andrew Wyllie, 
and Alistair Currie introduced the 
word “apoptosis” (from the Greek for 
apples falling off trees) to describe a 
special form of cell death. Apoptosis, 
or programmed cell death, is a normal 
physiological process in which speciﬁ  c 
signals trigger cells to self-destruct in a 
carefully choreographed manner. Without 
apoptosis, we would have paddles for 
hands, rather than individual ﬁ  ngers. And 
without apoptosis, we would be at much 
greater risk of developing cancer, since 
apoptotic mechanisms destroy cells that 
have taken the ﬁ  rst steps toward tumor 
formation.
Cells apoptose when the positive 
signals needed for their survival are 
withdrawn or when negative signals 
tell the cell to commit suicide. A cell 
undergoing apoptosis shrinks and 
develops “blebs”—small bubbles—on its 
surface, its mitochondria break down, and 
its genomic DNA breaks into fragments. 
Finally, the dead cell is engulfed by 
phagocytic cells, thus avoiding any 
inﬂ  ammation in surrounding tissues.
Apoptosis can be triggered by 
external and internal signals, but in 
both the extrinsic and intrinsic pathway 
of apoptosis, once a signal has been 
received, the next molecular step is 
caspase activation. These proteases, 
which cleave proteins at speciﬁ  c sites, 
fall into two classes. Initiator caspases 
activate themselves before proteolytically 
activating the effector (or executioner) 
caspases, which degrade numerous 
cellular proteins, thus causing cell death. 
All the caspases are made as inactive 
enzymes (zymogens); they are much 
too dangerous to be stored as active 
enzymes.
Yigong Shi and colleagues are 
studying the mysterious process of 
initiator caspase activation—the 
molecular mechanism of effector caspase 
activation is fairly well understood. The 
autocatalytic activation of caspase-
9, an initiator caspase in the intrinsic 
pathway of apoptosis, is mediated 
by the assembly of the apoptosome, 
a heptameric complex containing 
Apaf-1 (apoptotic protease activating 
factor 1) and cytochrome c. Caspase-
9 activation is currently explained 
by the induced proximity model in 
which the apoptosome, by increasing 
the local concentration of caspase-9, 
promotes its homodimerization (the 
formation of a complex containing two 
caspase-9 molecules) and subsequent 
autoactivation.
To test this model, Shi and coworkers 
engineered caspase-9 so that it exists in 
the cell all the time as a homodimer—
wild-type caspase-9 usually exists 
as monomer—and then examined 
its catalytic activity.  They found that 
Proximity- or Conformation-Induced Caspase Activation?
DOI: 10.1371/journal.pbio.0030198
DOI: 10.1371/journal.pbio.0030198.g001
Experiments with artiﬁ  cially joined 
molecules of caspase 9—which normally 
exists as monomers (above)—suggest that 
caspase 9 can’t activate cell death pathways 
by dimerization alone
could aggravate lung injury by inhibiting this protective 
pathway. But this protective pathway could potentially be 
restored, they argue, by artiﬁ  cially activating the inhibited 
pathway with therapeutic activators. Their results have important 
implications for how patients with ARDS and other serious lung 
diseases should be treated.
Hypoxia triggers a signaling pathway mediated by an 
adenosine receptor (called A2AR) that arrests inﬂ  ammation and 
tissue damage. It’s thought that this same hypoxia-driven pathway 
protects the lungs from the toxic effects of overactive immune 
cells called neutrophils. Using a mouse model of acute lung injury 
induced by bacterial infection, Thiel et al. exposed one group 
of mice to 100% oxygen, mimicking therapeutic oxygenation, 
and left another group at normal ambient levels (21% oxygen). 
Five times more mice died after receiving 100% oxygen than 
died breathing normal oxygen levels. Mice given 60% oxygen—
considered clinically safe—got worse, but didn’t die. 
To test the hypothesis that oxygen was precipitating these 
drastic results by exacerbating tissue inﬂ  ammation, the 
authors analyzed the neutrophil-mediated immune response. 
Establishing a correlation between high neutrophil count 
and increased capillary leakage—indicated by the protein 
concentrations recovered from the alveolar space, which 
mediates gas exchange—Thiel et al. conﬁ  rmed that overactive 
neutrophils promote lung injury. When otherwise healthy mice 
were subjected to lung infection and treated with hypoxia (10% 
oxygen), after 48 hours 90% of the mice showed several signs 
of improvement associated with an inhibition of neutrophil-
mediated inﬂ  ammation.
Thiel et al. went on to show that the adenosine receptor 
pathway was involved in the oxygen-dependent inﬂ  ammation. 
By isolating neutrophils from mice with inﬂ  amed lungs and 
exposing them to high concentrations of a molecule that 
activates the adenosine receptor, they triggered increased levels 
of both A2AR and cAMP, a molecule that inhibits inﬂ  ammation. No 
such increases were seen in mutant mice lacking functional A2AR
proteins. 
Hypoxia protects against lung damage, the authors conclude, 
by working through the A2AR signaling pathway to control 
inﬂ  ammation. Above-normal oxygen levels interrupt this 
anti-inﬂ  ammatory pathway, paving the way for further lung 
injury. Administering a molecule that jump-starts A2AR signaling 
artiﬁ  cially also signiﬁ  cantly reduced the pathological side effects 
of oxygenation. These results may help explain why some 
patients with ARDS die following oxygenation therapy. And by 
identifying the mechanism that is disrupted by oxygenation—
A2AR signaling—this study suggests that therapies aimed at 
activating the anti-inﬂ  ammatory A2AR pathway may allow 
patients to receive the beneﬁ  ts of oxygenation therapy without 
succumbing to its toxic effects. 
Thiel M, Chouker A, Ohta A, Jackson E, Caldwell C, et al. (2005) 
Oxygenation inhibits the physiological tissue-protecting mechanism 
and thereby exacerbates acute inﬂ  ammatory lung injury. DOI: 
10.1371/journal.pbio.0030174
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Seeing the world pass by as you’re 
moving is a complex feat. In ﬂ  ies, images 
moving across the eye—so-called optic 
ﬂ  ow—provide sensory information to 
neurons to guide behaviors like avoiding 
obstacles and chasing down mates. This 
maneuverability, combined with a fast 
image processing speed and the ease 
of examining ﬂ  y neurons, has made ﬂ  ies 
a popular model for dissecting how 
this occurs. But since much of what 
we know about how neurons process 
visual information comes from static 
situations—for example, placing a ﬂ  y in 
a ﬁ  xed position and presenting it with 
moving images—the question of how 
these processes naturally occur is largely 
unexplored.  
In a new study, a German and a Dutch 
group headed by Martin Egelhaaf and 
Roland Kern and by Hans van Hateren, 
respectively, joined forces to take the 
analysis of optic ﬂ  ow in the blowﬂ  y one 
step closer to the natural situation. To 
do this, they used a “panoramic virtual 
reality stimulator” to show a ﬂ  y in the 
laboratory what it would see while ﬂ  ying 
in nature. The authors combined this 
with measurements of the response of a 
motion-sensitive blowﬂ  y neuron, called 
the horizontal system equatorial (HSE) 
cell. 
The traditional model holds that the 
HSE cell extracts information about the 
motion of a ﬂ  y from optic ﬂ  ow. Previous 
work, which involved recording the 
responses of the HSE cell to simple 
visual stimuli (measured as a change 
of electrical potential of the neuron), 
suggested that HSE responds only to 
rotations of the visual world. However, 
the use of more natural visual stimuli 
suggests that some functions of the HSE 
cell may have been missed.
How HSE cells respond cannot be 
recorded in freely moving animals due to 
technical difﬁ  culties. To get around this 
problem, the Dutch group recorded the 
free ﬂ  ight of blowﬂ  ies, including their 
characteristic head and body movements. 
The visual stimuli during this behavior 
were then reconstructed in computer-
generated simulations and played back 
by the German group to ﬂ  ies in the 
panoramic virtual reality stimulator. 
Since this was done in the laboratory, the 
authors could record the responses of the 
HSE cell as the ﬂ  ies watched this movie.
Normal blowﬂ  y ﬂ  ight style involves 
a combination of saccadic (jerky) 
turns, where the head rotates at high 
velocity, and periods of forward motion 
accompanied by a constant gaze. During 
a playback of ten different versions of this 
behavior, the authors did not see a positive 
change in potential of the HSE cell during 
saccadic turns, as might be expected from 
previous conventional recordings. Instead, 
the HSE cell was depolarized by optic ﬂ  ow 
between saccades—when the ﬂ  y’s head 
was not rotating. 
This surprising result suggests that 
blowﬂ  ies may gather useful visual 
information about the world from 
translational (movement without 
rotation) optic ﬂ  ow—when their heads 
are not rotating and their gaze is ﬁ  xed. In 
fact, the authors found that the blowﬂ  y’s 
ﬂ  ight strategy allows information to be 
extracted from translational optic ﬂ  ow 
under situations where optic ﬂ  ow from 
rotation might otherwise dominate. 
Thus, HSE cells may not only encode 
information from dominant rotations of 
the ﬂ  y itself, but allow the ﬂ  y to extract 
“behaviorally relevant information” 
about the depth structure of the world. 
However, as the authors point out, it is 
not yet known whether the blowﬂ  y’s 
nervous system can garner rotational 
and translation information from the 
combined output of HSE cells. 
Nevertheless, through the use of a 
novel method to play back natural ﬂ  ight 
behaviors, the authors have been able to 
discern a new function for a well-studied 
motion-sensitive neuron—a function that 
appears to emerge from the blowﬂ  y’s 
own behavior. Future experiments can 
now begin to explore how the ﬂ  y uses 
the information generated by this new 
function. 
Kern R, van Hateren JH, Michaelis C, 
Lindemann JP, Egelhaaf M (2005) Function 
of a ﬂ  y motion-sensitive neuron matches 
eye movements during free ﬂ  ight. DOI: 
10.1371/journal.pbio.0030171
Fly Movie Theater Reveals Secrets of How Insects See the World 
DOI: 10.1371/journal.pbio.0030209 
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HSE neurons in the blowﬂ  y allow the ﬂ  y to 
extract visual information about the depth 
structure of the world during ﬂ  ight
although the engineered, dimeric 
caspase-9 was more active in in vitro 
assays and induced more cell death when 
expressed in cells than the wild-type 
enzyme, its activity was only a fraction 
of that of Apaf-1-activated wild-type 
caspase-9. Furthermore, its activity was 
not stimulated by Apaf-1, unlike that of 
the wild-type enzyme. Importantly, they 
also show that the crystal structure of their 
engineered caspase-9 closely resembled 
that of wild-type caspase-9, indicating that 
the changes they made did not cause any 
signiﬁ  cant changes in the protein.
Overall, their results led the 
researchers to suggest that the 
dimerization of caspase-9 may be 
qualitatively different from the Apaf-
1-mediated activation of caspase-9, 
and that dimerization may not be 
the major mechanism behind the 
activation of caspase-9. Instead, they 
suggest that a shape (conformational) 
change is induced in caspase-9 when 
it binds to the apoptosome and that 
this change drives its activation. This 
“induced conformation” model provides 
an alternative model to the induced 
proximity model for initiator caspase 
activation, but, as the researchers note, 
the two models need not be mutually 
exclusive. Indeed, only the determination 
of high-resolution structure of the 
apoptosome will unravel exactly how 
caspase-9 and other initiator caspases 
are activated.
Chao Y, Shiozaki EN, Srinivasula SM, Rigotti 
DJ, Fairman R, et al. (2005) Engineering 
a dimeric caspase-9: A re-evaluation 
of the induced proximity model for 
caspase activation. DOI: 10.1371/journal.
pbio.0030183
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The brain is arguably the most complex computing machine 
on the planet, with billions of individual neurons that process 
the input they receive from sensors in the body and from 
other neurons. The composition of channels that regulate 
electrical conductance across the neuronal membrane is a key 
determinant of the exact pattern of a neuron’s response to the 
stimuli it receives. Bursting—brief epochs of rapid ﬁ  ring—is one 
such pattern, while single spiking, with longer intervals between 
ﬁ  ring, is another. 
In a deep-seated part of the cerebral cortex, the hippocampus 
receives input from and sends output to widespread regions of 
the brain; information processing in the hippocampus is thought 
to underlie aspects of memory. The output of the hippocampus 
is handled by a subregion, the subiculum, that exhibits response 
modes that correspond to either bursting or single-spike 
response patterns. In this issue, Don Cooper, Sungkwon Chung, 
and Nelson Spruston show that the bursting–spiking switch 
is controlled by a new and surprisingly simple mechanism, 
prolonged inactivation (shutting off) of channels that conduct 
sodium ions through the membrane.
Working with rats, the authors measured activity from bursting 
subicular neurons in vivo, and observed frequent transitions 
from bursting to single spiking. Bursting tended to occur after 
long silent periods, while single spiking predominated after 
short intervals. To determine what drove this change from 
bursting to single spiking, they examined electric activity in brain 
slices. The switch was strongest when neurons were stimulated 
at frequencies between 1 and 10 Hertz, which suggested 
an inactivation and recovery process, perhaps mediated by 
prolonged inactivation of a small number of sodium channels. To 
test this hypothesis, the authors applied a very low concentration 
of tetrodotoxin, a neurotoxin from puffer ﬁ  sh that speciﬁ  cally 
blocks sodium channels. Indeed, blocking 16% of the channels 
with the toxin induced a switch from bursting to single spiking 
even at very low frequency stimulation, when subicular neurons 
normally maintain their bursting pattern. 
Output mode switching by the sustained inactivation of 
sodium channels is a novel mechanism for controlling the 
dynamics of neural networks. While the functional signiﬁ  cance 
of the switch remains unexplored, the authors point out that 
bursting is known to effectively activate target structures. 
It may be that switching from bursting to single spiking 
sustains activation of the target once it has been “woken up” 
by bursting. Conversely, transitions from a powerful burst 
output to less powerful single-spike mode may serve to 
initially activate target structures but then allow other inputs 
to govern the target output. Given the importance of the 
hippocampus in processing memory and emotion, and its 
involvement in schizophrenia, epilepsy, and other disorders, 
these new insights into the regulation of its output may lead to 
a better understanding of numerous fundamental higher brain 
processes.
Cooper DC, Chung S, Spruston N (2005) Output-mode transitions are 
controlled by prolonged inactivation of sodium channels in pyramidal 
neurons of subiculum. DOI: 10.1371/journal.pbio.0030175
Switching Signals in the Brain
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An acrylic painting by Don Cooper and Leah Leverich shows the 
transition zone between the densely packed pyramidal neurons in 
the CA1 region (right) and the spread-out pyramidal neurons within 
the subiculum (left)
Like other complex organs, the brain 
develops in stages, under tight control 
of multiple genetic signals. The key to 
understanding brain development, 
therefore, lies in understanding what 
these signals are, where they act, and 
what their effects are. The SOX family of 
transcription factors has emerged as a 
major group of developmental regulators 
in the brain, but their exact roles are 
not well known. In this issue, Vasso 
Episkopou and colleagues show that 
the mouse gene Sox1 is required for the 
differentiation and migration of neurons 
within a portion of the developing brain.
A major event in brain development is 
the emergence of the lateral ganglionic 
eminence (LGE), a bulbous protrusion 
whose neurons go on to form several 
vital brain structures, including the 
ventral striatum (VS), which is ultimately 
responsible for control of various aspects 
of motor, cognitive, and emotional 
functions. Several transcription factors 
have been shown to operate within the 
LGE precursors of the VS, but these are 
not present after these neurons have 
stopped dividing. To determine whether 
the protein SOX1 might be playing a role 
in these cells, the authors examined mice 
missing the SOX1 protein only in these 
cells. They found that the absence of the 
protein from these post-mitotic cells 
(cells after cell division) prevented normal 
Migration and Fate Speciﬁ  cation in the Ventral Striatum 
DOI: 10.1371/journal.pbio.0030226
DOI: 10.1371/journal.pbio.0030226.g001
Sox1 gene expression in wild-type (left) and 
Sox1 mutant (right) mouse forebrain
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development of two VS structures, the 
striatal bridges and the olfactory tubercles. 
It appeared that the defect in mice 
missing SOX1 from all cells was not in 
the proliferation of neuronal precursors, 
which appeared normal, but instead in 
their differentiation and migration. And 
while the previously identiﬁ  ed factors 
played no role after the neurons had 
stopped dividing, continued expression 
of Sox1 in post-mitotic neurons was 
required for correct speciﬁ  cation of cell 
identity. Overexpression of Sox1, on the 
other hand, did not increase the normal 
number of olfactory tubercle–speciﬁ  ed 
neurons, or alter their migration, 
suggesting that regulation of these cells 
is under more complex layers of control.
These results, combined with previous 
work by the same authors showing a role 
for Sox1 in terminal differentiation of the 
mouse lens, suggest that Sox1 and other 
closely related family members may help 
specify and maintain ﬁ  nal post-mitotic 
cell identity in a variety of tissue types.
Ekonomou A, Kazanis I, Malas S, Wood 
H, Alifragis P, et al. (2005) Neuronal 
migration and ventral subtype identity in 
the telencephalon depend on SOX1. DOI: 
10.1371/journal.pbio.0030186
After the wounded soldier in Dalton 
Trumbo’s Johnny Got His Gun slowly 
realizes he has no limbs, no face, ears, 
eyes, or mouth—but isn’t dead because 
his mind continues to think—he 
desperately tries to ﬁ  nd a way to reclaim 
his humanity. He decides to track time: he 
counts to sixty, ﬁ  les that minute “in one 
side of his mind . . . and [begins] counting 
from one to sixty again.” When he starts 
to wonder whether he’s counting at the 
right speed, his mind slips “off track” and 
his ﬁ  gures disappear. 
People have been known to exhibit 
enhanced memory in extraordinary 
circumstances, but human memory 
has its limits. Short-term retention of 
information, called working memory, 
involves doing at least two things 
simultaneously: paying attention to 
the task at hand—in the soldier’s case, 
counting—while processing that 
information and deciding how to handle 
it—adding the numbers and keeping a 
running total. The secondary processing 
of stored information is referred to as 
executive control. Many studies suggest 
that the neural seat of both working 
memory and executive control—which 
together encompass planning, creativity, 
reasoning, abstraction, and most of the 
other higher-order cognitive properties 
humans like to claim as their own—lies 
within the prefrontal cortex. Teasing 
out the neural components of these 
overlapping processes has proven 
challenging.
In a new study, Jonas Rose and Michael 
Colombo investigate the neural basis of 
executive control by training homing 
pigeons to remember or forget a visual 
stimulus. Recording from the nidopallium 
caudolaterale (NCL), a region of the 
avian brain considered analogous to the 
mammalian prefrontal cortex, the authors 
show that neurons in the NCL selectively 
ﬁ  re when the birds are told to remember 
and stop ﬁ  ring when they are told to 
forget. 
To test the hypothesis that the NCL 
plays a role in executive control, the 
authors trained ﬁ  ve pigeons on a directed 
forgetting test, a variation on the classic 
match-to-sample test. After viewing 
sample stimuli consisting of one of two 
shapes (a circle or dot) or colors (red or 
white), the birds were cued to remember 
or forget the sample (signaled by either 
a high- or low-frequency tone or one 
of two distinct patterns). A delay period 
followed these cues. If a forget cue was 
presented, the trial ended after the delay, 
and no memory test was given. If the 
remember cue was presented, the birds 
were given a memory test in which they 
saw two stimuli after the delay; if they 
responded to the sample stimulus (by 
pecking on a key), they were rewarded 
with wheat. The pigeons’ NCL activity was 
recorded during the trials.
Eighty-three of the 124 recorded 
neurons were classiﬁ  ed as delay neurons 
because they showed signiﬁ  cantly 
different activity during the delay period, 
when memory was required, than during 
the intervals between trials, when it was 
not. During the remember trials, neurons 
showed sustained activation throughout 
the cue and delay periods; during 
the forget trials, sustained activation 
disappeared. To make sure the forget cue 
was indeed directing the birds to forget 
the sample stimulus, the authors ran the 
forget trials again, but this time, tricked 
the birds and gave them a memory test. 
The birds consistently performed worse 
on the forget trials than on the remember 
trials, conﬁ  rming the forget cue’s effect. 
These results suggest that sustained 
NCL neuronal activation reﬂ  ects 
working memory or at least some type 
of cognitive activity associated with a 
working memory task. Either way, these 
ﬁ  ndings support the notion that NCL 
neurons play a role in executive control—
what to remember and what to forget—
by linking the presence or absence of 
neuronal activity with remembering and 
forgetting. And though the avian NCL 
and mammalian prefrontal cortex clearly 
differ after 320 million years of divergent 
evolution, Rose and Colombo make a 
strong case that they are similar enough 
to support the NCL’s likely contribution 
to executive control in mammals as 
well. And they suggest that seeing such 
similarities between the bird and human 
brain forces us to reexamine not only our 
notions of how these structures operate 
but also our hubris in thinking our 
biology and nature is unique. 
Jonas Rose, Michael Colombo (2005) Rose 
J, Colombo M (2005) Neural correlates of 
executive control in the avian brain. DOI: 
10.1371/journal.pbio.0030190
A Place in the Brain for Remembering and Forgetting
DOI: 10.1371/journal.pbio.0030216
DOI: 10.1371/journal.pbio.0030216.g001
Neurons in the avian version of the 
prefrontal cortex ﬁ  re when pigeons 
perform memory tasks and may play a 
role in higher cognitive processes such as 
decision making and reasoning
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Of the 200 or so diseases collectively known as cancer, tumors 
of the soft tissue include some of the rarest and most diverse. 
Malignant soft tissue tumors, or sarcomas, and benign soft tissue 
tumors—which together comprise over 100 subtypes—take 
root in immature nerve and mesenchymal cells, which give rise 
to muscle, fat, cartilage, and other connective tissues. Reﬂ  ecting 
the ubiquitous nature of connective tissue, soft tissue sarcomas 
can occur nearly anywhere in the body. Pathologists classify soft 
tumor sarcomas based on the proteins they express and on their 
resemblance to normal connective tissue cells (such as adipocytes, 
smooth muscle cells, and ﬁ  broblasts): tumors consisting of 
cells with cytologic features of fat cells, for example, are called 
liposarcomas while those forming the spindle-shaped, organized 
sheets typical of smooth muscle cells are called leiomyosarcomas. 
But many connective cells appear too similar and express too 
many of the same proteins for traditional screens to distinguish 
among them. Assays are further complicated by the admixture 
of non-malignant cells, including inﬂ  ammatory cells and those 
recruited to form new blood vessels, into the soft tissue tumor 
landscape. 
In a new study, Robert West, Matt van de Rijn, and their 
colleagues investigate the notion that different types of 
ﬁ  broblastic tumors mirror the features of normal ﬁ  broblasts and 
search for tissue markers that might distinguish them. Using DNA 
microarrays, the authors proﬁ  led gene expression patterns in two 
types of ﬁ  broblastic tumors and found signiﬁ  cant differences 
in the expression of functionally related genes, conﬁ  rming that 
each tumor carries a unique genetic signature. These gene sets 
also appear in the matrix of normal connective tissue, or stroma, 
leading to the identiﬁ  cation of two noncancerous ﬁ  broblast 
subtypes.
The tumors analyzed in this study—solitary ﬁ  brous tumor 
(SFT) and desmoid-type ﬁ  bromatosis (DTF)—behave differently 
but consist of cells that look similar under the microscope, 
making them well suited to the task of identifying novel 
connective tissue markers. Typically benign, SFT tumors 
respond well to surgical excision and are thought to arise either 
from ﬁ  broblasts, most frequently in the thoracic cavity. DTFs, 
aggressive tumors found deep within the soft tissue of the trunk, 
abdomen, or extremities, are difﬁ  cult to excise completely and 
are also thought to arise from ﬁ  broblasts. 
Gene arrays taken from ten DTF tumors and 13 SFT tumors 
showed that each tumor type had distinct gene expression 
patterns reﬂ  ecting different gene functions. For example, DTF 
gene proﬁ  les included many genes involved in ﬁ  brosis (scarring) 
and extracellular matrix remodeling, a prerequisite for the invasive 
behavior of aggressive DTF tumors. SFTs, on the other hand, 
express many genes involved in synthesis and maintenance of the 
basement membrane that surrounds muscle cells, blood vessels, 
and other specialized cells. Based on these variable expression 
patterns, the authors hypothesized that the tumors’ cells of origin 
might perform different functions in normal tissue. 
Next, West et al. examined gene expression patterns in 
ﬁ  broblasts found in normal tissue samples to look for tumor-
speciﬁ  c markers. As predicted, DTF markers were found in one 
set of tissues—related to scarring and inﬂ  ammation—and SFT 
markers were found in another—breast and skin ﬁ  broblasts, and 
benign breast growths. The authors’ use of soft tissue tumors to 
deﬁ  ne different subsets of stromal cells is similar to past studies 
that used lymphomas to discover novel subsets of normal 
lymphoid cells. 
Because normal ﬁ  broblasts can contribute to cancer 
progression—by providing the cellular matrix, or stroma, that 
supports tumor growth—the authors looked for DTF- or SFT-
speciﬁ  c markers in the stroma of breast cancer patients. Two 
groups, the authors note, showed differences in the expression of 
DTF and SFT genes. Patients with tumors showing high DTF gene 
expression had the best prognosis, suggesting that tumor–
stromal interactions might affect disease progression. 
The difﬁ  culty of classifying ﬁ  broblasts has complicated 
efforts to understand how ﬁ  broblasts aid tumor progression. 
This study suggests that breast cancers with different stromal 
signatures may have different clinical outcomes, which raises 
many questions for future study. If the same tumor type grows 
on a different stromal background, will it progress differently? If 
so, how do tumor–stromal interactions inﬂ  uence progression? 
Thanks to the ﬁ  broblast markers identiﬁ  ed here, scientists have 
new tools for exploring these questions.
West RB, Nuyten SA, Subramanian S, Nielsen TO, Corless CL, et 
al. (2005) Determination of stromal signatures in breast carcinoma. 
DOI: 10.1371/journal.pbio.0030187
Microarrays Highlight Tumor–Connective Tissue Interactions in Cancer Outcomes
DOI: 10.1371/journal.pbio.0030220
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Tissue samples at 600× magniﬁ  cation show that these two soft 
tissue tumors express different protein markers: solitary ﬁ  brous 
tumors express the APOD protein marker (top), and desmoid-type 
ﬁ  bromatosis tumors express OSF2
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